Skip to Main content Skip to Navigation
Journal articles

Multiple System Atrophy: Recent Developments and Future Perspectives

Abstract : Multiple system atrophy (MSA) is a rare and fatal neurodegenerative disorder characterized by a variable combination of parkinsonism, cerebellar impairment, and autonomic dysfunction. The pathologic hallmark is the accumulation of aggregated α-synuclein in oligodendrocytes, forming glial cytoplasmic inclusions, which qualifies MSA as a synucleinopathy together with Parkinson's disease and dementia with Lewy bodies. The underlying pathogenesis is still not well understood. Some symptomatic treatments are available, whereas neuroprotection remains an urgent unmet treatment need. In this review, we critically appraise significant developments of the past decade with emphasis on pathogenesis, diagnosis, prognosis, and treatment development. We further discuss unsolved questions and highlight some perspectives.
Document type :
Journal articles
Complete list of metadata

Cited literature [157 references]  Display  Hide  Download
Contributor : Benjamin Dehay Connect in order to contact the contributor
Submitted on : Tuesday, January 14, 2020 - 4:09:10 PM
Last modification on : Monday, July 4, 2022 - 9:44:18 AM
Long-term archiving on: : Wednesday, April 15, 2020 - 8:06:19 PM


 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document



Wassilios Meissner, Pierre‐olivier Fernagut, Benjamin Dehay, Patrice Péran, Anne Pavy‐le Traon, et al.. Multiple System Atrophy: Recent Developments and Future Perspectives. Movement Disorders, Wiley, 2019, 34 (11), pp.1629-1642. ⟨10.1002/mds.27894⟩. ⟨inserm-02439518⟩



Record views